Doctors discover a new early warning sign for one of the deadliest cancers
Researchers at the University of California - San Diego looked at mice who were genetically engineered to mimic the early stages of pancreatic cancer, which kills nearly nine in 10 patients within five years.
Looking at cells under a microscope, they found cell stress and inflammation could be early warning signs of the disease as it can cause cancer cells to activate the protein STAT3, which has been shown to help tumors survive and resist treatment.
STAT3 then turns on the protein Integrin β3 (ITGB3) in mouse and human cells, which fuels the growth of pancreatic ductal adenocarcinoma (PDAC), the most common form of pancreatic cancer.
This causes PDAC to spread faster and become more difficult to treat.
Inflammation and cellular stress cause by chemotherapy also activated STAT3, increasing ITGB3 expression and further spreading the disease.
Based on the findings, researchers believe blocking STAT3 could stop tumors from forming while pancreatic cancer is still in its early stages.
Because most pancreatic cancers are only diagnosed after they have already spread, this could improve the overall survival rate.
David Cherish, study author and pathologist at UC San Diego, told Newsweek: 'Given the fact that STAT3 plays such an important role in many cancers and the fact that it controls so many genes prompted us to drill down on which genes in particular are associated with cancer development, progression and drug resistance.'
The team also noted the findings could lead to early treatments fo lung, breast and skin cancers.
Pancreatic cancer affects roughly 67,000 Americans every year and kills about 52,000.
More than half the time, the disease is first spotted after it has already reached stage three or four due to its vague symptoms. These include abdominal pain, weight loss, back pain, jaundice and floating or clay-colored stools.
This leads patients to assume their symptoms are from more benign causes like irritable bowel syndrome (IBS).
By the time it reaches stage four, the five-year survival rate is just three percent, making it virtually incurable.
It's unclear exactly what causes pancreatic cancer, but smoking, obesity and diabetes are thought to increase the risk by inducing harmful inflammation that causes cells to divide and become mutated more easily.
In the new study, published Tuesday in the journal Cell Reports, researchers genetically engineered mice to have a mutation in their KRAS gene, which raises the risk of lung, colorectal and pancreatic cancers.
This was done to help mimic early pancreatic cancer in humans.
The team found in the presence of inflammatory proteins and stress induced by low oxygen levels - which makes cancer cells more invasive and treatment resistant - STAT3 activates ITGB3 in both mouse and human pancreas cells, which accelerates the growth of pancreatic cancer cells.
This created a harmful loop between STAT3 and ITGB3, which caused tumors to become more aggressive and spread more easily.
However, when researchers used cancer drugs to target STAT3 early, cancer development slowed and became less aggressive, keeping it from spreading to other organs and becoming more difficult to treat.
In total, STAT3 induces the expression of 10 genes, including ITGB3, which form a gene signature the researchers dubbed 'STRESS UP.'
The team believes detecting the STRESS UP signal early can help predict whether precancerous cells will turn into pancreatic cancer and determine how aggressive a tumor may become.
Cheresh said: 'Having knowledge of this gene signature in patients could be valuable since there are known drugs on the market for other diseases that block STAT3 activation and thereby inhibit the expression of the STRESS UP genes in cancer cells.'
He noted STRESS UP could be used to help develop early screening tools for pancreatic cancer, as there is currently no way to test for it until symptoms develop.
The team now plans to explore molecules that could stop inflammation from activating ITGB3 not only in pancreatic cancer but also other forms of the disease that can affect the surface of tissues. These include lung, breast and skin cancers.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Daily Mail
2 hours ago
- Daily Mail
EXCLUSIVE New mom details shocking cost of giving birth in America
A new mom has shared the shockingly high cost of giving birth in America - and it's well over six figures. Emily Fisher, 36, from Columbus, Ohio, welcomed twin girls last month and was left stunned when she saw an insurance claim come through for her delivery that was over $10,000. Completely shocked by the immense figure, she decided to go back and total up all the bills she had received over the course of her pregnancy to determine just how much having a baby in the US really costs. And after adding everything up, Emily found that having her baby girls would have cost her a whopping $120,527.51 had she not had insurance. She shared her findings in a video shared to TikTok earlier this month and it quickly went viral, leaving thousands across the globe just as surprised as she was. 'So I am five weeks postpartum with twin girls and I've been seeing a lot of headlines recently about how the birth rate in America is declining and how concerning that is,' Emily began in the video. 'I thought to myself, I could think of a lot of reasons why the birth rate might be declining. First and foremost, cost. 'So I decided to take it upon myself and look at every bill that I received over the course of my pregnancy and total what it costs to deliver twins in America.' Emily explained that she is considered 'advanced maternal age' and was pregnant with 'dichorionic diamniotic twins' which made her pregnancy 'high risk.' In addition, about halfway through the pregnancy her doctor raised concerns about potential 'fetal growth restriction,' so from about 22 weeks on she had to have two appointments every week with her OBGYN and a maternal fetal medicine specialist to make sure the babies were healthy. 'So what was the total cost of that? From the start of my pregnancy through delivery and me walking out of those hospital doors, the total bill for my care was $120,527.51,' she said in the video. 'Now I am very fortunate great insurance and I have a low deductible so over the course of my pregnancy out of pocket I paid $2,038.70. 'I know that is relatively good but still, $2,000 for something that is considered necessary and vital to the future of America is pretty significant.' Emily added that on top of that, her newborns both received bills for their delivery. 'It's kind of funny, they're not even able to blink yet and they've already been billed more than the total cost of my student loans,' she continued. 'Baby A received a bill for $15,124.55 and Baby B was billed $14,875.55, I guess there was some sort of sibling discount. She added, 'The total cost I owed for those two bills was $750, which was the cost of my deductible.' The bills are seen above 'The total cost I owed for those two bills was $750, which was the cost of my deductible.' She then broke down what some of the highest costs were during the pregnancy. Unsurprisingly, the delivery itself and the hospital stay afterwards was the most costly expense. Emily explained that she had a scheduled C-section at 37 weeks and spent four days in the hospital post delivery, and the total cost of her care before insurance was $65,665.50. The second highest cost during the pregnancy was an appointment she had about seven months in, during which she complained to her doctor that she was having headaches. She said they took her blood pressure and it was slightly elevated, so they monitored the heart rate of the babies for 20 minutes to 'make sure they were okay.' She was then given 'two extra strength Tylenol' and they 'did some blood work.' 'The cost that was billed to my insurance for that visit was $9,115,' shared the new mom. 'All things considered, I'm very grateful for the experience that I had and very grateful to have great insurance, but I know that for a lot of people who live in America that is simply not possible,' she concluded. 'And if I did not have insurance delivery my two baby girls, I would not be able to afford it. 'In fact, I probably would have had to file bankruptcy had I not had insurance. So when people act confused why the birth rates are down, maybe it's not necessarily all attributed to lifestyle choices, maybe it's not because people aren't feeling the vibe of having kids, maybe it's because the cost of having a baby in America is over six figures.' While chatting with the Daily Mail about it, Emily, who used to work on the healthcare space, said she believes the insurance system in America 'needs a complete overhaul.' 'Given that the US is the one of (if not the only) developed nation in the world without some sort of universal healthcare, we're falling behind,' she said. 'People are spending too much on basic and necessary care. Medical debt is one of the number one reasons for bankruptcy in the US, and it shouldn't be that way. 'If we invested in a system that put the health its people first, everyone would be better off. 'And given the decline in birth rates, if our politicians are genuinely concerned about falling birth rates, they would be incentivizing people to have children. You shouldn't have to pay to give birth.' She added that while she was 'shocked' by the high number that her insurance was billed, she was 'not surprised at the same time.' 'The first thing that came to mind when I saw the total was, "How do people without insurance afford this?"' she shared. 'But I've always known that healthcare in America is a business. Ultimately, like most necessities in the US, privatized insurance is designed to make money.' She said she certainly wasn't expecting her video, which was viewed more than one million times, to get as much attention as it did, but she's so glad that it has sparked a conversation. 'I hope my video makes people think twice about having kids in America. Because until the system is redesigned to truly support the people, we shouldn't be buying into it,' she concluded. 'I'm fortunate to have good health coverage. I'm not on the hook for much as far as the cost of my pregnancy, but that is only the beginning for my family and what we'll pay to raise my kids. 'Now we have to think about things like paying for their health coverage, daycare, food, housing and college. 'All of these things are only getting more and more expensive and almost unreachable for people.'
Reuters
3 hours ago
- Reuters
Sarepta shares rebound after shipments of gene therapy Elevidys resume in US
July 29 (Reuters) - Sarepta Therapeutics (SRPT.O), opens new tab shares surged more than 30% before the bell on Tuesday, as analysts said the resumption of U.S. shipments for its muscular gene therapy partially removes financial headwinds and decreases the risk of market withdrawal. The company said on Monday it would resume shipments of Elevidys — approved in the U.S. to treat a rare condition called Duchenne muscular dystrophy — to patients who can walk. U.S. shipments to patients who cannot walk independently are still halted, following the death of two teenage boys earlier this year. These incidents brought heightened regulatory scrutiny to Sarepta in recent weeks, while the pause of shipments raised concerns about the future of Elevidys — the company's largest revenue generator. Sarepta's announcement followed the U.S. Food and Drug Administration's recommendation that the voluntary hold on shipments be removed after a probe showed the death of an 8-year-old boy in Brazil was not related to Elevidys. Wall Street analysts said the resumption of shipments would allow Sarepta to fulfill its near-term payments to partner Arrowhead (ARWR.O), opens new tab and maintain access to its debt facilities. "The FDA's recommendation and the resumption of commercial treatment in the U.S. virtually eliminate the risk of Elevidys being formally withdrawn from the market," said William Blair analyst Sami Corwin. While the decision allows some patients to regain access to the treatment, analysts warned that patients and doctors could show hesitancy in light of the recent hit to reputation. "It remains to be seen how the news headlines regarding the patient deaths will affect commercial interest in the near term," Corwin said. Sarepta's partner Roche (ROG.S), opens new tab had also stopped Elevidys shipments in certain countries outside the U.S. Shares of Sarepta surged 36% to $18.85 in premarket trading. They have fallen more than 80% since the first Elevidys-related death was reported in March.
Daily Mail
3 hours ago
- Daily Mail
Scientists discover remarkable health impact of a daily 'fast walk'
Hitting 10,000 steps a day is a goal for millions of us—but we should be focusing on the pace not the paces, according to a new study. Research suggests that going on a daily brisk 15-minute walk could boost heart health and reduce risk of death by 19 per cent. US researchers, who studied more than 79,850 adults from low-income areas, found that a short brisk walk was more beneficial than walking at a slower pace for three hours, even when overall leisure-time physical activity levels were accounted for. Experts argued that the findings show that walking, particularly at a brisk pace, is an effective form of exercise—especially for those in low income areas— that could protect against heart disease. It comes as alarming data released last year revealed that premature deaths from cardiovascular problems, such as heart attacks and strokes, had hit their highest level in more than a decade. In the UK, around 420 people of working age die of as a result of heart disease each week, which works out as 21,975 people a year. In the current study, which analysed data from the Southern Community Cohort Study between 2002 and 2009, participants reported how many minutes they spent per day engaging in walking slowly and walking fast. Walking at work, engaging in light exercise or walking the dog were classed as 'walking slowly', whereas more dynamic activities such as climbing the stairs, brisk walking and exercise were considered fast. Over a follow-up of just under 17 years, the researchers discovered that walking fast for as little as 15 minutes per day reduced the risk of all cause mortality by nearly 20 per cent. Writing in the American Journal of Preventive Medicine, they found the effect was most pronounced for cardiovascular disease. According to Professor Wei Zeng, lead investigator and expert in lifestyle factors and diseases, fast walking could reduce cardiovascular mortality by improving how efficiently the heart works and reducing obesity. This style of exercise has previously been shown to increase VO2-max —a measure of how much oxygen the body can process during exercise. A high VO2 max is associated with better physical fitness and lower risk of cardiovascular disease, indicating that the body is efficiently extracting and using oxygen from the blood. Prof Zeng concluded: 'Brisk walking offers a convenient, accessible and low-impact activity that individuals of all ages and fitness levels can use to improve general health and cardiovascular health specifically.' The experts, lead by Professor Lili Liu, lead author and trainee epidemiologist, are now urging health officials to encourage fast walking within all communities—especially those with limited access to healthcare—and address barriers to daily walking such as safety concerns. They added: 'Public health campaigns and community-based programmes can emphasise the importance and availability of fast walking to improve health outcomes. NHS data shows a rise in the number of younger adults suffering from heart attacks over the past decade. The biggest increase (95 per cent) was recorded in the 25-29 year-old demographic, though as numbers of patients are low even small spikes can look dramatic 'Individuals should strive to incorporate more intense physical activity into their routines, such as brisk walking or other forms of aerobic exercise.' The scientists, however, acknowledged that because physical activity data was only collected at the beginning of the study, changes in activity levels could not be considered. The paper also had some limitations, they said, including the fact daily walking levels were self-reported. Sedentary lifestyles in the UK, with Brits spending their workhours deskbound, then sitting in a train or car on their way home to sit down in front of the TV, have been estimated to kill thousands each year. The WHO puts the annual global death toll from physical inactivity at around 2million per year, making it in the running to be among the top 10 leading causes of global death and disability. Physical inactivity has been long linked to health problems like cardiovascular disease as well contributing to health problems like obesity, itself linked to an increased risk of type 2 diabetes and some cancers. Cases of heart attacks, heart failure and strokes among the under-75s had tumbled since the 1960s thanks to plummeting smoking rates, advanced surgical techniques and breakthroughs such as stents and statins. But now, other factors such as slow ambulance response times for category 2 calls in England — which includes suspected heart attacks and strokes — as well as long waits for tests and treatment have also been blamed.
